Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dolutegravir in severely immunocompromised AIDS patients
NCT01837277Phase 3Completed
- Sponsor
- Fundação Bahiana de Infectologia
- Start
- Dec 2017
- Primary completion
- Jul 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of dolutegravir in human immunodeficiency virus infection (HIV), sponsored by Fundação Bahiana de Infectologia. Started Dec 2017; status: completed.
02
Drugs
dolutegravir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT01837277.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01837277.